Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Yuxiao Wang
Advertisement
Yuxiao Wang works within ZS’s clinical development quality, operations and risk management practice, and is a consultant at the Princeton, New Jersey, office.
Articles by Yuxiao Wang
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
2
Answering the Sustainability Call: Digital Health Technologies and eCOA
3
KRI Overload: When More Isn’t Better
4
Addressing Preclinical Gaps to Prevent Biotech Trial Delays
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
